Effect of a gastrin-releasing peptide receptor antagonist and a proton pump inhibitor association in an animal model of gastritis

Peptides

Volumn 30, Issue 8, 2009, Pages 1460-1465

  Petronilho, Fabricia ^a,b   Araújo, João H ^a   Steckert, Amanda V ^a   Rezin, Gislaine T ^a   Ferreira, Gabriela K ^a   Roesler, Rafael ^b,c   Schwartsmann, Gilberto ^c   Dal Pizzol, Felipe ^a,b   Streck, Emilio L ^a  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Gastritis; Indomethacin; Omeprazole; Oxidative stress; RC 3095

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; CARBONYL DERIVATIVE; GASTRIN; GASTRIN RELEASING PEPTIDE; HORMONE RECEPTOR BLOCKING AGENT; INDOMETACIN; NEUROPEPTIDE; OMEPRAZOLE; PROTON PUMP INHIBITOR; RC 3095; REACTIVE OXYGEN METABOLITE; RO 3095; SUPEROXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GASTRITIS; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; STOMACH INJURY; STOMACH MUCOSA LESION; STOMACH PROTECTION; STOMACH SECRETION; STOMACH ULCER; WISTAR RAT;

ANIMALS; BOMBESIN; DISEASE MODELS, ANIMAL; GASTRIC MUCOSA; GASTRITIS; INDOMETHACIN; LIPID PEROXIDATION; MALE; MITOCHONDRIA; OMEPRAZOLE; PEPTIDE FRAGMENTS; PROTEIN CARBONYLATION; PROTON PUMP INHIBITORS; RATS; RATS, WISTAR; RECEPTORS, BOMBESIN; SUPEROXIDES; THIOBARBITURATES;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 67650502806     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.04.026     Document Type: Article

References (36)

1. Beal M.F. Oxidatively modified proteins in aging and disease. Free Radicals in Biology and Medicine 32 (2002) 797-803
2. Benerjee D., Bauri A.K., Guha R.K., Bandyopadhyay S.K., and Chattopadhyay S. Healing properties of malabaricone B and malabaricone C, against indomethacin-induced gastric ulceration and mechanism of action. European Journal of Pharmacology 578 (2008) 300-312
3. Berlett B.S., and Stadman E.R. Protein oxidation in aging, disease, and oxidative stress. Journal of Biological Chemistry 272 (1997) 20313-20316
4. Blandizzi C., Fornai M., Colucci R., Natale G., Lubrano V., Vassalle C., et al. Lanzoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage. World Journal of Gastroenterology 11 (2005) 4053-4060
5. Dal-Pizzol F., Di Leone L.P., Ritter C., Martins M.R., Reinke A., Gelain D.P., et al. Gastrin-releasing peptide receptor antagonist effects on an animal model of sepsis. American Journal of Respiratory and Critical Care Medicine 173 (2006) 84-90
6. Dal-Pizzol F., Klamt F., Vianna M.R., Schroder N., Quevedo J., Benfato M.S., et al. Lipid peroxidation in hippocampus early and late after status epilepticus induced by pilocarpine or kainic acid in Wistar rats. Neuroscience Letters 291 (2000) 179-182
7. Draper H.H., and Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods in Enzymology 186 (1990) 421-431
8. Elliott S.L., Ferris R.J., Giraud A.S., Cook G.A., Skeljo M.V., and Yeomans N.D. Indomethacin damage to rat gastric mucosa is markedly dependent on luminal pH. Clinical and Experimental Pharmacology & Physiology 23 (1996) 432-434
9. English J.M., and Cobb M.H. Pharmacological inhibitors of MAPK pathways. Trends in Pharmacological Sciences 23 (2002) 40-45
10. Gamberini M.T., Skorupa L.A., Souccar C., and Lapa A.J. Inhibition of gastric secretion by a water extract from Baccharis triptera Mart. Memorias do Instituto Oswaldo Cruz 86 (1991) 137-139
11. García Rodríguez L.A., Cattaruzzi C., Troncon M.G., and Agostinis L. Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs. Archives of Internal Medicine 58 (1998) 33-39
12. Hawkey C.J. Nonsteroidal anti-inflammatory drug gastopathy. Gastroenterology 119 (2000) 521-535
13. Hersey S.J., and Sachs G. Gastric acid secretion. Physiological Reviews 75 (1995) 155-189
14. Hippisley-Cox J., Coupland C., and Logan R. Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ 331 (2005) 1310-1316
15. Hogben C.A.M., Schanker L.S., Tocco D.J., and Brodie B.B. Absorption of drugs from the stomach. II. The human. Journal of Pharmacology and Experimental Therapeutics 120 (1957) 540-545
16. Hung C.R., and Neu S.L. Acid-induced gastric damage in rats is aggravated by starvation and prevented by several nutrients. The Journal of Nutrition 127 (1997) 630-636
17. +-ATPase α-subunit gene expression. Biochemical and Biophysical Research Communications 290 (2002) 1289-1294
18. Lapenna D., de Goia S., Ciofani G., Festi D., and Cuccurullo F. Antioxidant properties of omeprazole. FEBS Letters 382 (1996) 189-192
19. Levine R.L., Garland D., and Oliver C.N. Determination of carbonyl content in oxidatively modified proteins. Methods in Enzymology 186 (1990) 464-478
20. Lowry O.H., Rosembrough A.L., and Randall R.J. Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 193 (1951) 265-275
21. Minamino N., Kangawa K., Matsuo H., and Neuromedin B. A novel bombesin-like peptide identified in porcine spinal cord. Biochemical and Biophysical Research Communications 114 (1983) 541-548
22. Odabasoglu F., Cakir A., Suleyman H., Aslan A., Bayir Y., Halici M., et al. Gastroprotective and antioxidant effects of usnic acid on indomethacin-induced gastric ulcer in rats. Journal of Ethnopharmacology 103 (2006) 59-65
23. Oliveira PG, Brenol CV, Edelweiss MI, Brenol JCT, Petronilho F, Roesler R, Dal-Pizzol F, Schwartsmann G, Xavier RM. Effects of an antagonist of the bombesin/gastrin-releasing peptide receptor on complete Freund's adjuvant-induced arthritis in rats. Peptides; 2008;29:1726-31.
24. Petronilho F., Roesler R., Schwarstmann G., and Dal-Pizzol F. Gastrin-releasing peptide receptor as a molecular target for inflammatory diseases. Inflammation & Allergy-Drug Targets 6 (2008) 197-200
25. Poderoso J.J., Carreras M.C., Lisdero C., and Boveris A. Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondrial and submitochondrial particles. Archives in Biochemistry & Biophysics 328 (1996) 85-92
26. Ritter C., Andrades M., Reinke A., Mena-Barreto S., Moreira J.C.F., and Dal-Pizzol F. Treatment with N-acetylcysteine plus deferoxamine protects rats against oxidative stress and improves survival in sepsis. Critical Care Medicine 32 (2004) 342-349
27. Robinson M. The pharmacodynamics and pharmacokinetics of próton pump inhibitors: overview and clinical implications. Alimentary Pharmacology & Therapeutics 20 (2004) 1-10
28. Roesler R., Luft T., Oliveira S.H.S., Farias C.B., Almeida V.R., Quevedo J., et al. Molecular mechanisms mediating gastrin-releasing peptide receptor modulation of memory consolidation in the hippocampus. Neuropharmacology 51 (2006) 350-357
29. Schubert M.L. Gastric secretion. Current Opinion in Gastroenterology 18 (2002) 639-649
30. Simon W.A., Sturm E., Hartmann H.J., and Weser U. Hidroxyl radical scavenging reactivity of proton pump inhibitors. Biochemical Pharmacology 71 (2006) 1337-1341
31. Smith V.C., Dhatt N., and Buchan A.M.J. The innervation of the human antro-pyloric region: organization and composition. Canadian Journal of Physiology and Pharmacology 79 (2001) 905-918
32. Souccar C., Cysneiros R.M., Tanae M.M., Torres L.M.B., Lima-Landman M.T.R., and Lapa A.J. Inhibition of gastric acid secretion by a standardized aqueous extract of Cecropia glaziovii Sneth and underlying mechanism. Phytomedicine 15 (2008) 462-469
33. Szepeshazi K., Schally A.V., and Gabor H. A single in vivo administration of bombesin antagonist RC-3095 reduces the levels and mRNA expression of epidermal growth factor receptors in MXT mouse mammary cancers. Proceedings of the National Academy of Sciences of the United States of America 94 (1997) 10913-10918
34. Wandall J.H. Effects of omeprazole on neutrophil chemotaxis, superoxide production, degranulation and translocation of cytochrome b-245. Gut 33 (1992) 617-621
35. Whittle B.J. Gastrointestinal effects of nonsteroidal anti-inflammatory drugs. Fundamental & Clinical Pharmacology 17 (2003) 301-313
36. Yeomans N.D., Tulassay Z., Juhász L., Rácz I., Howard J.M., van Rensburg C.J., et al. A comparison o omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. The New England Journal of Medicine 338 (1998) 719-726